Table 1.
Clinical characteristics of 213 ICC patients treated at Kyoto University Hospital between 1993 and 2013
| Variable | Resection n=164 | Non-resection n=49 | p-value |
|---|---|---|---|
| Age (years) | 0.26 | ||
| Median | 65 | 67 | |
| Range | 26–84 | 36–82 | |
| Gender | 0.91 | ||
| Male | 99 (60%) | 30 (61%) | |
| Child-Pugh classification B/C | 6 (4%) | 12 (24%) | <0.001* |
| CA19-9 levels (U/ml) | 0.0010* | ||
| Median | 60.1 | 436.1 | |
| Range | 0–29682 | 0–40357 | |
| IM | 36 (22%) | 19 (39%) | 0.018* |
| Tumor distribution: bilobar | 23 (64%) | 14 (74%) | 0.46 |
| Tumor number ≥5 | 11 (31%) | 8 (42%) | 0.39 |
| VI | 66 (40%) | 30 (61%) | 0.0096* |
| Portal venous invasion | 56 (34%) | 30 (61%) | <0.001* |
| Hepatic venous invasion | 28 (17%) | 18 (37%) | 0.0033* |
| Regional LM | 46 (28%) | 17 (35%) | 0.38 |
| Distant metastasis | 15 (9%) | 31 (63%) | <0.001* |
| AJCC/UICC classification | 0.031* | ||
| Stage I | 26 (16%) | 0 (0%) | |
| Stage II | 19 (12%) | 7 (14%) | |
| Stage III | 27 (16%) | 10 (20%) | |
| Stage IV | 92 (56%) | 32 (65%) |
*
Significantly different. AJCC/UICC=American Joint Committee on Cancer/Union for International Cancer Control.